New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2013
11:51 EDTALXN, FFIVStocks with call strike movement; FFIV ALXN
F5 Networks (FFIV) April 110 call option implied volatility decreased 2% to 32, Alexion (ALXN) May 110 call option implied volatility increased 2% to 31 according to iVolatility.
News For FFIV;ALXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 27, 2014
08:15 EDTALXNAlexion says NICE recommends Soliris for aHUS patients
Subscribe for More Information
November 26, 2014
11:08 EDTFFIVSony Pictures hack highlights need for more IT security spending, analyst says
Subscribe for More Information
November 25, 2014
06:35 EDTALXNAlexion's Soliris granted ODD in Japan
Alexion Pharmaceuticals announced that Soliris, or eculizumab, has been granted orphan drug designation, or ODD, by Japanís Ministry of Health, Labour and Welfare for the treatment of patients with neuromyelitis optica, or NMO, a life-threatening, ultra-rare neurologic disorder. In patients with NMO, chronic, uncontrolled complement activation results in severe damage to the central nervous system, predominantly impacting the optic nerve and spinal cord.1-3 This devastating disease is characterized by severe weakness, paralysis, respiratory failure, loss of bowel and bladder function, blindness and premature death.4-6
November 20, 2014
07:09 EDTALXNAlexion management to meet with Deutsche Bank
Subscribe for More Information
November 19, 2014
10:28 EDTALXNAlexion management to meet with Deutsche Bank
Subscribe for More Information
07:40 EDTFFIVUBS to hold a conference
Global Technology Conference to be held in Sausalito, California on November 18-20 with webcasted company presentations to begin on November 19 at 10:45 am; not all company presentations may be webcasted.Webcast Link
November 18, 2014
07:52 EDTALXNFDA Drug Safety & Risk Management Advisory Committee to hold a meeting
The Committee discusses the risk management of Alexion Pharmaceuticals' Eculizumab (Soliris) is a meeting being held at FDA Silver Spring, Maryland offices on November 18 at 9 am. Webcast Link
November 17, 2014
06:48 EDTFFIVState Department hacked, NY Times reports
Subscribe for More Information
November 16, 2014
13:04 EDTALXNAlexion says data supports effectiveness of sustained Soliris treatment in aHUS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use